ArticleCancer research2011

Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity.

Satoshi Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.